StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SHHARICH.BO$105.00-7.69%
Fair $105.00+0.0%

SHHARICH.BO

Shree Hari Chemicals Export Limited

Basic Materials / Specialty ChemicalsBSE

$105.00

-8.75 (-7.69%)

Fairly Valued+0.0%Fair Value $105.00Fund rank 22/100 · Data gapFallback financials|
SA 41/C
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 16%

FCF escenarios

weak_data · normalized FCF $-61.0M · quality 33.7/100

Data gap 22/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 10/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

41/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · SHHARICH.BOLocal privado en este navegador · Shree Hari Chemicals Export Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$663M

P/E

15.0x

↓

EV/EBITDA

9.8x

↓

ROE

9.3%

↑

Gross Margin

31.9%

↑

Debt/Equity

0.75

↑
52-Week Range$105
$88$162

TradingView lightweight chart

SHHARICH.BO price, volumen y niveles de valoración

Último $105.00Periodo +3718.2%
Fair value: $105.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+21.6%

FCF CAGR

—

FCF margin

-3.4%

FCF / Net income

-1.53x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.85B · net income $41.2M · FCF $-63.0M

2023-FY → 2026-FY

Gross margin

31.9%+36.5% pts

Operating margin

2.3%+27.1% pts

Net margin

2.2%+21.5% pts

FCF margin

-3.4%+2.4% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$1.85B$1.85B$1.41B$1.37B$1.03B
Net Income$41.2M$41.2M$51.0M$22.9M$-198.0M
EBITDA$97.0M$97.0M$114.5M$78.8M$-225.9M
EPS——8.725.16-44.54
Gross Margin31.9%31.9%43.7%18.1%-4.7%
Operating Margin2.3%2.3%6.0%3.7%-24.8%
Net Margin2.2%2.2%3.6%1.7%-19.3%
Balance Sheet
Debt/Equity0.750.750.821.321.66
Current Ratio0.950.95———
Cash Flow
Free Cash Flow$-63.0M$-63.0M$-61.0M$80.1M$-59.2M
Returns
ROE9.3%9.3%15.9%11.3%-110.3%
Valuation
P/E15.0415.0417.7214.84—
EV/EBITDA9.789.7810.127.24—
P/B1.501.502.821.681.12
Growth & Yield
Revenue Growth30.7%30.7%2.7%34.1%—
EPS Growth——69.0%111.6%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -32.9%

Total return

-32.9%

Start / end P/E

n/dx → n/dx

EPS bridge

8.72 → n/d

Residual

-32.9%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-32.9%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.